Collectively, we identified six DDR-related prognostic genes, namely, CDC25C, NEIL3, H2AFX, NBN, XRCC5, and RAD1, which may be promising therapeutic targets as well as prognostic markers for NSCLC. This evidence concerns the gene NBN and non-small cell lung carcinoma.